603739.SH
Qingdao Vland Biotech, Inc.
SSE · Healthcare · Biotechnology · CN
CNY 11.75
+1.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 32.80x
- P/E 2027E
- 31.03x
- P/E 2028E
- 29.82x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 42.59x
- PEG TTM
- —
- Price / book
- 1.66x
- Price / sales
- 2.07x
- Price / cash flow
- 23.31x
Enterprise value
- Enterprise value
- CNY 3.5B
- EV / sales
- 2.48x
- EV / EBITDA
- 14.12x
- EV / EBIT
- 25.67x
- Market cap
- CNY 3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026